Mus vs Oman: Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC
Mus
93.0%
in 2025
Oman
99.0%
in 2025
Mus rank
1st
Oman rank
1st
Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC over time
- Mus
- Oman
How they compare
Oman currently reports 99.0% against 93.0% in Mus, a difference of 6.0%.
That makes Oman's figure about 1.1 times Mus's.
Across all 26 years both countries report, Oman has been ahead every year.
Mus ranks 1st and Oman ranks 1st of 2 regions.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.1% | 97.8% | 48.7% | Oman |
| 2010s | 92.0% | 98.9% | 6.9% | Oman |
| 2020s | 94.5% | 98.8% | 4.3% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Mus or Oman?
- Oman, at 99.0% against 93.0% in Mus as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Mus and Oman?
- 6.0%, with Oman ahead.
- How many years of comparable data are there for Mus and Oman?
- 26 years are reported by both, from 2000 to 2025.
- How do Mus and Oman rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Mus ranks 1st and Oman ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.